Raisio’s updated financial targets for the strategy period 2022-2025
Our Healthy Growth strategy is built on three focus areas: Benecol® and plant stanol ester solutions, value added oats and ingredients and plant proteins.
Long-term financial targets has been updated on December 14, 2022.
- the compound annual growth rate (CAGR) for the entire Raisio Group is 9% (previously 5%)
- the CAGR of the combined net sales of the three strategic focus areas (Benecol® and plant stanol ester solutions; value added oat products and ingredients; plant proteins) is 11% (previously 7%)
- comparable EBIT of over 13% of the Group’s net sales in 2025 (previously over 10%).
Food for Health, Heart and Earth.
Responsibility is our strategy
Raisio’s purpose “Food for Health, Heart and Earth” guides our operations, and responsibility is part of our strategy and everyday work.
Our responsibility programme, Good Food Plan 2022–2025, is part of the company’s Healthy Growth Strategy that aims, among other things, to make us a forerunner in responsibility.
Learn more about Good Food Plan 2022–2025
Strong financial standing enables growth
and rewarding shareholders
Our strong financial standing creates a solid basis for accelerating growth during the strategy period. Although we have invested a total of nearly EUR 70 million in our production facilities and our expertise in plant-based foods and related technologies during the last three years, our financial position has remained strong.
Our goal is to reward shareholders also in the coming years of building growth and to pay an annual dividend of 50–100% of the company’s earnings per share. In addition, we aim to return value to shareholders through, for example, payment of extra dividends and other ways made possible by a strong balance sheet.
